Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 260

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Protection against cognitive deficits and markers of neurodegeneration by long‐term oral administration of melatonin in a transgenic model of Alzheimer disease

Olcese, James M., Cao, Chuanhai, Mori, Takashi, Mamcarz, Malgorzata B., Maxwell, Anne, Runfeldt, Melissa J., Wang, Li, Zhang, Chi, Lin, Xiaoyang, Zhang, Guixin, Arendash, Gary W.·2009·Journal of Pineal Research

Abstract

Abstract: The neurohormone melatonin has been reported to exert anti‐β‐amyloid aggregation, antioxidant, and anti‐inflammatory actions in various in vitro and animal models. To comprehensively determine the potential for long‐term melatonin treatment to protect Alzheimer’s transgenic mice against cognitive impairment and development of β‐amyloid (Aβ) neuropathology, we administered melatonin (100 mg/L drinking water) to APP + PS1 double transgenic (Tg) mice from 2–2.5 months of age to their killing at age 7.5 months. A comprehensive behavioral battery administered during the final 6 weeks of treatment revealed that Tg mice given melatonin were protected from cognitive impairment in a variety of tasks of working memory, spatial reference learning/memory, and basic mnemonic function; Tg control mice remained impaired in all of these cognitive tasks/domains. Immunoreactive Aβ deposition was significantly reduced in hippocampus (43%) and entorhinal cortex (37%) of melatonin‐treated Tg mice. Although soluble and oligomeric forms of Aβ1‐40 and 1‐42 were unchanged in the hippocampus and cortex of the same melatonin‐treated Tg mice, their plasma Aβ levels were elevated. These Aβ results, together with our concurrent demonstration that melatonin suppresses Aβ aggregation in brain homogenates, are consistent with a melatonin‐facilitated removal of Aβ from the brain. Inflammatory cytokines such as tumor necrosis factor (TNF)‐α were decreased in hippocampus (but not plasma) of Tg+ melatonin mice. Finally, the cortical mRNA expression of three antioxidant enzymes (SOD‐1, glutathione peroxidase, and catalase) was significantly reduced to non‐Tg levels by long‐term melatonin treatment in Tg mice. Thus, melatonin’s cognitive benefits could involve its anti‐Aβ aggregation, anti‐inflammatory, and/or antioxidant properties. Our findings provide support for long‐term melatonin therapy as a primary or complementary strategy for abating the progression of Alzheimer disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1600-079x.2009.00692.x

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 64 references

Cited by

See all 260

Metadata

Authors
Olcese, J. M., Cao, C., Mori, T., Mamcarz, M. B., Maxwell, A., Runfeldt, M. J., Wang, L., Zhang, C., Lin, X., Zhang, G., & Arendash, G. W.
Venue
Journal of Pineal Research
Publisher
Wiley
Published
2009-07
Volume
47
Issue
1
Pages
82-96
ISSN
  • 0742-3098 (ISSN-L)
  • 1600-079X
OpenAlex
W2155856211
Cited by
260
References
64
FWCI
16.73
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Protection against cognitive deficits and markers of neurodegeneration by long‐term oral administration of melatonin in a transgenic model of Alzheimer disease. https://app.cochat.ai/papers/10.1111/j.1600-079x.2009.00692.x
The paper
Olcese, J. M., Cao, C., Mori, T., Mamcarz, M. B., Maxwell, A., Runfeldt, M. J., Wang, L., Zhang, C., Lin, X., Zhang, G., & Arendash, G. W. (2009). Protection against cognitive deficits and markers of neurodegeneration by long‐term oral administration of melatonin in a transgenic model of Alzheimer disease. Journal of Pineal Research. https://doi.org/10.1111/j.1600-079x.2009.00692.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.